Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNorthRock Partners, LLC
Latest Disclosed Ownership2,516 shares
Latest Disclosed Value $ 350,720
NorthRock Partners, LLC reports 2.25% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - NorthRock Partners, LLC filed a 13F-HR form disclosing ownership of 2,516 shares of Gilead Sciences, Inc. (CH:GILD) valued at $350,720 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,574 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.25% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,516 -58 -2.25 351 10.76 0.0057
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,574 -13,144 -83.62 316 -81.88 0.0053
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 15,718 2,796 21.64 1,745 21.79 0.0315
2025-11-14 2025-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 12,922 1,290 11.09 1,433 9.90 0.0373
2025-07-25 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,922 1,290 1,433 0.0370
2025-05-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 11,632 425 3.79 1,303 25.89 0.0437
2025-04-22 2024-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 11,207 920 8.94 1,035 20.07 0.0337
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 11,207 920 1,035 0.0338
2025-04-22 2024-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 10,287 1,276 14.16 862 39.48 0.0284
2024-10-30 2024-09-30 13F GILEAD SCIENCES COM 375558103 2,947 -6,064 247 0.0218
2025-04-22 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 9,011 -264 -2.85 618 -8.98 0.0232
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,784 -5,491 260 0.0233
2025-04-22 2024-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 9,275 -1,623 -14.89 679 -23.02 0.0261
2024-05-07 2024-03-31 13F GILEAD SCIENCES COM 375558103 3,968 -6,930 291 0.0246
2025-04-22 2023-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 10,898 7,082 185.59 883 209.47 0.0369
2024-02-08 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,732 1,916 464 0.0433
2023-10-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 3,816 96 2.58 286 -0.35 0.0298
2023-08-02 2023-06-30 13F GILEAD SCIENCES COM 375558103 3,720 -470 -11.22 287 -17.58 0.0314
2023-05-04 2023-03-31 13F GILEAD SCIENCES COM 375558103 4,190 -583 -12.21 348 -15.16 0.0370
2023-02-01 2022-12-31 13F GILEAD SCIENCES COM 375558103 4,773 633 15.29 410 60.39 0.0466
2022-11-02 2022-09-30 13F GILEAD SCIENCES COM 375558103 4,140 445 12.04 255 11.84 0.0296
2022-08-04 2022-06-30 13F GILEAD SCIENCES COM 375558103 3,695 3,695 228 0.0237
2022-05-05 2022-03-31 13F GILEAD SCIENCES COM 375558103 0 -2,768 -100.00 0 -100.00
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 2,768 -3,554 -56.22 201 -54.52 0.0151
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 6,322 1,009 18.99 442 20.77 0.0361
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 5,313 5,313 366 0.0306
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,587 -100.00 0 -100.00
2020-08-13 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,587 632 21.39 276 24.89 0.0327
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,583 628 276 32,680.4738
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 2,955 -9,464 -76.21 221 -72.61 0.0310
2020-02-12 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 12,419 823 7.10 807 9.80 0.0852
2020-02-12 2019-12-31 13F GILEAD SCIENCES COM 375558103 13,377 1,781 807 85,246.7190
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 11,596 11,596 735 0.1002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.